Events

Reset
  • 20/03/2019

    ARECOR RECEIVES REGULATORY APPROVAL TO INITIATE PHASE I CLINICAL TRIAL FOR ULTRA-RAPID ACTING INSULIN PRODUCT

  • 11/03/2019

    PROACTIVEINVESTORS interview with CEO Sarah Howell re Arecor’s strengthening of its team with the appointment of an experienced Chief financial Officer

  • 11/03/2019

    Arecor Appoints Chief Financial Officer